Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $45.2650 (7.9%) ($45.2650 - $45.2650) on Tue. Mar. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.43% (three month average) | RSI | 48 | Latest Price | $45.2650(7.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.3% a day on average for past five trading days. | Weekly Trend | TGTX declines -3.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(64%) ARKK(59%) IBB(59%) IWO(59%) | Factors Impacting TGTX price | TGTX will decline at least -3.215% in a week (0% probabilities). VIXM(-42%) VXX(-36%) UUP(-19%) UNG(-2%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.215% (StdDev 6.43%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $33.68(-25.59%) | Resistance Level | $45.38 | 5 Day Moving Average | $42.99(5.29%) | 10 Day Moving Average | $43.67(3.65%) | 20 Day Moving Average | $45.38(-0.25%) | To recent high | -17.3% | To recent low | 52.7% | Market Cap | $5.733b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |